Labetalol treatment aggravates estrogen-induced cholestasis von Sá, I. C. Igreja, Tripká, K., Micuda, S., Nachtigal, P.

Volltext

Carotuximab effects on endoglin expression and signaling in 7-ketocholesterol induced endothelial dysfunction in HAECs von Tripká, K., Vicen, M., Havelek, R., Sá, I. C. Igreja, Eissazadeh, S., Vitverová, B., Nachtigal, P.

Volltext

Treatment with lipoprotein apheresis is associated with significant decrease of biomarkers related to endothelial dysfunction and inflammation not only after each procedure but in... von Blaha, V., Blaha, M., Lánská, M., Andrýs, C., Tebbens, J.D., Sá, I. C. Igreja, Tripská, K., Vicen, M., Víšek, J., Lášticová, M., Nachtigal, P.

Volltext

Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients von Víšek, J, Bláha, M, Bláha, V, Lášticová, M, Lánska, M, Andrýs, C, Tebbens, J Duintjer, Igreja E Sá, Ivone Cristina, Tripská, K, Vicen, M, Najmanová, I, Nachtigal, P

Volltext

Critical impact of endoglin blockage in endothelial dysfunction induced by hypercholesterolemia and hyperglycemia in human aortic endothelial cells von Tripská, K., Igreja Sá, I.C., Vicen, M., Eissazadeh, S., Svobodová, Z., Vitverová, B., Havelek, R., Theuer, C., Bernabeu, C., Nachtigal, P.

Volltext